• MWE Medical Wire
  • Feather Safety Razor
  • We make diagnostics that matter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe, it’s free!
  • Search
  • Menu Menu
Clinical Laboratory int.

Archive for category: Product News

Product News

Retinol-Binding Protein (RBP), and other urinary low molecular weight protein assays, as markers of renal tubular function

, 26 August 2020/in Product News /by 3wmedia

TRIMERO Diagnostics offers IVD CE urinary assays of low molecular weight proteins, by nephelometry or turbidimetry, for the assessment of renal tubular function:

  • Retinol-Binding Protein (RBP)
  • Alpha-1 Microglobulin (α1μ)
  • Cystatin C (CysC)
  • Beta-2 Microglobulin (β2μ)
  • KLoneus® Kappa and Lambda Free Light Chains (FLC)
  • Kappa and Lambda (B&F) Light Chains

These assays, specifically designed for their use on urine samples, are available for the nephelometers and the most popular clinical chemistry analyzers present in the market.
Other TRIMERO’s available nephelometric and turbidimetric assays include:
Serum Amyloid A (SAA), IgD Immunoglobulins, Soluble Transferrin Receptor (sTfR), Hemopexin, Complement C1q, Complement C5, Factor B (C3 Proactivator), C1 (Esterase) Inhibitor.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/CLI_200616_doc_image_tubular-markers-_HR_.jpg 883 723 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:30Retinol-Binding Protein (RBP), and other urinary low molecular weight protein assays, as markers of renal tubular function

Compact random access analyser

, 26 August 2020/in Product News /by 3wmedia

The RA Analyzer 10 is a compact random access device which provides fully automated processing of chemiluminescence immunoassays (ChLIA) for autoimmune and infection diagnostics as well as antigen detection. It is ideal for use in small- to medium-sized laboratories, or to complement high-throughput-devices in large laboratories.
The device allows continuous loading, also as part of a laboratory track system, ensuring that every sample is processed with minimal effort as a single determination. Up to 85 results can be obtained per hour. EUROIMMUN ChLIA technology offers short reaction times, with first results in just 25 minutes. Test- and lot-specific information, including stored standard curves, is imported by means of RFID codes, enabling error-free and convenient loading, along with efficient and secure test evaluation. Automatic identification of samples and reagents by means of barcodes ensures complete traceability. The system offers preferential processing of emergency samples (STAT), giving laboratories unparalleled flexibility in their laboratory routine.
New CE-marked EUROIMMUN ChLIA for use on the RA Analyzer 10 are available for detection of antibodies against Borrelia (IgG, IgM) Epstein-Barr virus (EBV-CA IgG, IgM; EBNA IgG), proteinase 3 (PR3, IgG) and phospholipase A2 receptor (PLA2R, IgG). Further ChLIA for detection of antibodies against tissue transglutaminase (tTG, IgA), CCP (IgG), myeloperoxidase (MPO, IgG), parvovirus B19 (IgG, IgM), HSV-1 (IgG) and HSV-2 (IgG), as well as calprotectin and biomarkers in Alzheimer’s disease will be available soon. Assays for many other parameters are under development.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/PRODUCT_CLI_EUROIMMUN.jpg 576 751 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:38Compact random access analyser

Hemoglobin A1c test available on Atellica

, 26 August 2020/in Product News /by 3wmedia

Siemens Healthineers recently announced the global availability of its new Atellica CH Enzymatic Hemoglobin A1c (A1c_E) Assay to assist clinicians in diagnosing and monitoring diabetes. The International Diabetes Federation projects 642 million people worldwide will have diabetes by 2040 because of leading factors such as higher levels of urbanization, aging populations, and the growing adoption of more sedentary lifestyles which leads to insufficient physical activity, greater rates of obesity and a higher intake of unhealthy foods. When diagnosed, treated and monitored regularly, diabetes is manageable and, in some cases, reversible. Left untreated, however, blood sugar can rise to dangerous levels and lead to kidney damage and other irreversible health consequences. As diabetes awareness increases and screening for the chronic disease rises, testing options for the clinical laboratory are evolving both in sophistication and practicality. The Siemens Healthineers Atellica CH Enzymatic Hemoglobin A1c meets new standards of testing and offers laboratories improved performance – both precision and accuracy – over leading  alternative methodologies. Instruments with higher throughput capabilities offer laboratories the ability to run a greater volume of tests and produce patient results more quickly, thus improving patient satisfaction. Laboratories are seeking HbA1c assays that can be integrated onto chemistry testing platforms and that provide the accurate and precise results patients deserve. The new Atellica CH Enzymatic Hemoglobin A1c Assay offers these capabilities.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C443_SIEMENS_Hemoglobin_A1c_Test.jpg 450 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:47Hemoglobin A1c test available on Atellica

Awareness Technology releases ChemWell 2, a two-plate ELISA and chemiluminescent analyzer

, 26 August 2020/in Product News /by 3wmedia

Awareness Technology’s new ChemWell 2 analyzer for ELISA and chemiluminescent (CLIA) is now available.
The ChemWell 2 is a two-probe, two-plate automatic combo analyzer. For 20 years the company has produced single-plate ChemWell automatic ELISA and CLIA systems with the flexibility to run both modes simultaneously even within the same plate. With laboratories expanding serology requirements, the two-plate system is expected to be a more suitable primary instrument for lower throughput labs, and ideal for off-line assays in higher throughput settings.
ChemWell’s flexibility in both hardware and software is key to automating a wide variety of unrelated test methods. Separate probes are used for samples and reagents with an option for disposable tips. Filters range from 405 nm – 630 nm; dispense volume from 2μL to 1.95 ml; plate washing routines, temperature control, and mixing are programmable. Intuitive software offers on-board predilutions, multiple calibration options, replicates, statistics, QC tracking, barcoded sample ID and data management. Additionally, it schedules assays to prevent timing conflicts while providing optimal throughput. An optional laptop stand conserves bench space.
For more information, visit: www.awaretech.com
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/PRODUCT_AWARENESS_TECHNOLOGY.jpg 461 729 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:33Awareness Technology releases ChemWell 2, a two-plate ELISA and chemiluminescent analyzer

Centrifuge with full colour touchscreen

, 26 August 2020/in Product News /by 3wmedia

Featuring an ergonomically enhanced, novel industrial design complemented by a wide range of rotors, the Thermo Scientific general purpose Pro Centrifuge Series has been developed to deliver a safe and regulatory-compliant benchtop separation solution to meet an array of application needs, from clinical protocols and cell culture procedures to microplate processing. The series has been equipped with an advanced touchscreen interface that gives users easy access to prestored protocols, temperature control and system health checks to improve productivity and reduce time spent performing manual maintenance. The general purpose Pro Centrifuge Series provides scientists with: a unique glass touchscreen that facilitates a simpler user interface for immediate, effortless workflow and operation monitoring, and easy cleaning; an ergonomically enhanced industrial design that enables the quick and safe change of any of its 19 rotor types in just three seconds through its Auto-Lock rotor exchange function; superior sample capacity, performance and bio-containment through its Fiberlite carbon fibre rotors and ClickSeal biocontainment lids; a compact separation solution fea-turing connectivity-ready technology, while optimizing benchtop space. The ge-neral purpose Pro Centrifuge Series meets global compliance standards and includes the Thermo Scientific Sorvall, Thermo Scientific Multifuge and Thermo Scientific Megafuge configurations, which can be easily configured with a selection of rotors to address a range of application needs.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/Thermo_General_Purpose_Pro_Centrifuge_Series.jpg 600 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:43Centrifuge with full colour touchscreen

Thrombin generation now available in laboratories

, 26 August 2020/in Product News /by 3wmedia

The new ST Genesia analyser is designed to automate and standardize results for thrombin generation. For laboratories, this is a significant step forward for assisting with assessment of thrombotic and hemorrhagic risks in patients.
ST Genesia is an automated analyser, based on the same principles as the CAT system, which measures thrombin generation. Designed to support clinical applications in the lab, the key difference between systems is that CAT’s main purpose is for research and development.
ST Genesia aims at standardizing and automating the thrombin generation test in order to make it widely accessible and available for use in in-vitro diagnostics (IVD). ST Genesia is designed to add to the information usually provided by routine tests (TP, TCA, etc.) or specialized tests (Anti-Xa, ECA) and offer an improved assessment of thrombotic and hemorrhagic risks.
A range of reagents specifically developed for ST Genesia is available including STG-ThromboScreen for thrombin generation assessment in patients who are likely to suffer from thrombophilia; STG-BleedScreen for thrombin generation assessment in patients with bleeding risk, such as hemophiliacs; STG-DrugScreen for assessment of the effect of anticoagulants on treated patients, which could be useful for people at risk of drug accumulation (impaired renal function, people over 75, etc.).

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C439_STAGO_ST_Genesia.jpg 600 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:50Thrombin generation now available in laboratories
Page 106 of 106«‹104105106
Click here for more information!

Latest issue of Clinical laboratory

June 2022

22 June 2022

Beckman Coulter partners with Smart4Diagnostics to reduce preanalytical errors between blood collection and lab analysis

20 June 2022

Werfen

20 June 2022

Werfen

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release

Parklaan 54a
5613 BH
Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only